发明名称 |
Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
摘要 |
A pharmaceutical composition comprising
(+)-1-(cyclohexyloxycarbonyloxy)ethyl
2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H -benzimidazole-7-carboxylate,
2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H -benzimidazole-7-carboxylic acid,
2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl)bi phenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid,
or a salt thereof, in combination with at least one species selected from the group consisting of:
- 2,4-oxazolidinedione derivative or a salt thereof;
- valiolamine derivative or a salt thereof and acarbose or a salt thereof;
- indane derivative;
- N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-N-(indan-2-yl)glycine or a salt thereof; and
- (+)-3R,5S-erythro-(E)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxymethylpyridin-3-yl]-3,5-dihydroxyhept -6-enoic acid or a salt thereof.
|
申请公布号 |
EP2253327(A1) |
申请公布日期 |
2010.11.24 |
申请号 |
EP20100173392 |
申请日期 |
1997.04.03 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED |
发明人 |
TAMURA, NORIKAZU;SOHDA, TAKASHI;IKEDA, HITOSHI |
分类号 |
A61K31/222;A61K31/4184;A61K45/06;A61K31/133;A61K31/41;A61K31/415;A61K31/425;A61K31/44;A61K38/04;A61P3/06;A61P3/08;A61P3/10;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P13/02;A61P15/00;A61P17/00;A61P25/00;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P27/02;A61P43/00;C07D403/10;C07D413/10;C07D413/14;C07D417/10 |
主分类号 |
A61K31/222 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|